TUESDAY, Oct. 1, 2024 (HealthDay News) — Besides being useless in altering a person’s sexuality or gender identity, so-called “conversion therapy” or “conversion practice” can greatly raise the odds that an LGBT person experiences mental health issues, new research finds. Questionnaires completed by over 4,400 LGBTQ+ Americans found that havingContinue Reading

MONDAY, Sept. 30, 2024 (HealthDay News) — A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer’s, new research shows. Synthetic THC (dronabinol) also gave patients’ caregivers a boost, according to findings presented Thursday at a meeting of the International Psychogeriatrics Association in BuenosContinue Reading

FRIDAY, Sept. 27, 2024 (HealthDay News) — The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they’ve long hoped for: A means of easing the hallucinations and “voices”Continue Reading